EVOZYNE
Updates & Highlights
Biotech Veteran Marc Yoskowitz Named Evozyne CEO
Biotech Veteran Marc Yoskowitz Named Evozyne CEO
Business Wire · over 2 years ago
Evozyne: Novel Protein Systems Company Closes $81 Million In Series B Funding
Evozyne: Novel Protein Systems Company Closes $81 Million In Series B Funding
Pulse 2.0 · over 2 years ago
Evozyne raises $81 million to put AI to work on therapeutic drug development
Evozyne raises $81 million to put AI to work on therapeutic drug development
Crain's Chicago Business · over 2 years ago
Recent Openings
View all 2 jobsAll Jobs
Culture & Mission
Benefits & Perks
Learning Budget
Professional development
Competitive Salary
Market-rate compensation
Equity/Stock Options
Ownership in the company
Health Insurance
Medical, dental & vision
Remote Work
Work from anywhere flexibility
Generous PTO
Paid time off
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Evozyne?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company →News & Press
15 recentBiotech Veteran Marc Yoskowitz Named Evozyne CEO
Biotech Veteran Marc Yoskowitz Named Evozyne CEO
Business Wire · over 2 years ago
Evozyne: Novel Protein Systems Company Closes $81 Million In Series B Funding
Evozyne: Novel Protein Systems Company Closes $81 Million In Series B Funding
Pulse 2.0 · over 2 years ago
Evozyne raises $81 million to put AI to work on therapeutic drug development
Evozyne raises $81 million to put AI to work on therapeutic drug development
Crain's Chicago Business · over 2 years ago
Generative AI-focused biotech startup Evozyne raises $81m
Generative AI-focused biotech startup Evozyne raises $81m
Pharmaceutical Technology · over 2 years ago
Evozyne Raises $81M in Series B Financing
Evozyne Raises $81M in Series B Financing
FinSMEs · over 2 years ago
Biotech Biz Evozyne Closes $81M Series B Funding Round
Biotech Biz Evozyne Closes $81M Series B Funding Round
Law360 · over 2 years ago
Evozyne Announces $81 Million Financing Round to Advance Generative AI for Therapeutic Discovery and Drug Development
Evozyne Announces $81 Million Financing Round to Advance Generative AI for Therapeutic Discovery and Drug Development
Business Wire · over 2 years ago
Startup Evozyne identifies ‘supernatural’ proteins with Nvidia’s pretrained AI model
Startup Evozyne identifies ‘supernatural’ proteins with Nvidia’s pretrained AI model
drugdiscoverytrends.com · over 3 years ago
Evozyne Uses NVIDIA BioNeMo to Create Proteins and Accelerate Drug Discovery
Evozyne Uses NVIDIA BioNeMo to Create Proteins and Accelerate Drug Discovery
StorageReview.com · over 3 years ago
NVIDIA, Evozyne Create Generative AI Model for Proteins
NVIDIA, Evozyne Create Generative AI Model for Proteins
NVIDIA Blog · over 3 years ago
Mike Gamson takes over as CEO at biotech startup Evozyne
Mike Gamson takes over as CEO at biotech startup Evozyne
The Business Journals · over 3 years ago
Tech exec Mike Gamson named CEO at biotech startup Evozyne
Tech exec Mike Gamson named CEO at biotech startup Evozyne
Crain's Chicago Business · over 3 years ago
Evozyne, Takeda ink $400M deal
Evozyne, Takeda ink $400M deal
Crain's Chicago Business · about 4 years ago
Takeda/Evozyne Partnership Headlines Hot Week for Gene Therapy Deals
Takeda/Evozyne Partnership Headlines Hot Week for Gene Therapy Deals
BioSpace · about 4 years ago
Takeda's gene therapy hunger not yet quelled as Evozyne pact extended for $400M in biobucks
Takeda's gene therapy hunger not yet quelled as Evozyne pact extended for $400M in biobucks
Fierce Biotech · about 4 years ago